Found: 47
Select item for more details and to access through your institution.
Patient and Healthcare Provider Perspectives on the Pathway to Diagnosis of Seborrheic Dermatitis in the United States.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 12, p. 4433, doi. 10.1007/s12325-024-02986-8
- By:
- Publication type:
- Article
More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 4, p. 1, doi. 10.1007/s00403-024-02830-7
- By:
- Publication type:
- Article
Evaluation of a patient education platform for seborrheic dermatitis.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 10, p. 2927, doi. 10.1007/s00403-023-02681-8
- By:
- Publication type:
- Article
Financial burden and impact of atopic dermatitis out-of-pocket healthcare expenses among black individuals in the United States.
- Published in:
- Archives of Dermatological Research, 2022, v. 314, n. 8, p. 739, doi. 10.1007/s00403-021-02282-3
- By:
- Publication type:
- Article
The Global Prevalence of Seborrheic Dermatitis: A Systematic Review and Meta-Analysis.
- Published in:
- JAMA Dermatology, 2024, v. 160, n. 8, p. 846, doi. 10.1001/jamadermatol.2024.1987
- By:
- Publication type:
- Article
Capturing the Diversity of Dermatology—What's in a Name?
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 675, doi. 10.1007/s40257-023-00800-9
- By:
- Publication type:
- Article
Atopic Dermatitis Across Shades of Skin.
- Published in:
- American Journal of Clinical Dermatology, 2023, v. 24, n. 5, p. 731, doi. 10.1007/s40257-023-00797-1
- By:
- Publication type:
- Article
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 459, doi. 10.1007/s40257-022-00697-w
- By:
- Publication type:
- Article
The Clinical Diversity of Atopic Dermatitis.
- Published in:
- Cutis, 2023, v. 112, n. 4, p. E32, doi. 10.12788/cutis.0887
- By:
- Publication type:
- Article
Understanding disparities in hidradenitis suppurativa through social and structural determinants of health.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 4, p. 945, doi. 10.1002/jvc2.409
- By:
- Publication type:
- Article
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 8, p. 2171, doi. 10.1007/s13555-024-01225-w
- By:
- Publication type:
- Article
Evaluating Access to Prescription Medications in the Atopic Dermatitis Patient Population in the USA.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 7, p. 1811, doi. 10.1007/s13555-024-01205-0
- By:
- Publication type:
- Article
When Patient Diversity Informs Formulation: Reimagining Treatment for Seborrheic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1071, doi. 10.1007/s13555-024-01161-9
- By:
- Publication type:
- Article
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 5, p. 1127, doi. 10.1007/s13555-024-01157-5
- By:
- Publication type:
- Article
The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 2, p. 323, doi. 10.1007/s13555-024-01099-y
- By:
- Publication type:
- Article
Association of pemphigus and pemphigoid with osteoporosis and pathological fractures.
- Published in:
- Archives of Dermatological Research, 2020, v. 312, n. 4, p. 263, doi. 10.1007/s00403-019-02010-y
- By:
- Publication type:
- Article
Abrocitinib may improve itch and quality of life in patients with itch‐dominant atopic dermatitis.
- Published in:
- Skin Health & Disease, 2024, v. 4, n. 4, p. 1, doi. 10.1002/ski2.382
- By:
- Publication type:
- Article
730 - Patient opinions on healthcare provider interactions and current treatment satisfaction in adults with atopic dermatitis by race and ethnicity.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.103
- By:
- Publication type:
- Article
708 - Raising the bar of efficacy in atopic dermatitis: lebrikizumab maintains depth of response over 2 years.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.082
- By:
- Publication type:
- Article
705 - Patient preferences for atopic dermatitis treatment profiles: results from a discrete choice experiment.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.079
- By:
- Publication type:
- Article
698 - Impact of amlitelimab (an anti-OX40 ligand antibody) on clinical outcome assessments for atopic dermatitis: results from the 52-week STREAM-AD phase 2b study in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.072
- By:
- Publication type:
- Article
670 - Tapinarof cream 1% once daily is efficacious for the treatment of atopic dermatitis in patients with skin of color down to 2 years of age in two pivotal phase 3 trials.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.044
- By:
- Publication type:
- Article
651 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.030
- By:
- Publication type:
- Article
630 - Efficacy comparison of targeted systemic monotherapies including lebrikizumab for moderate-to-severe atopic dermatitis: a network meta-analysis.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.014
- By:
- Publication type:
- Article
622 - Shifting the care paradigm for individuals with skin of color (SOC): a comprehensive review of care gaps and emerging initiatives in dermatology.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.006
- By:
- Publication type:
- Article
594 - United States prevalence of atopic dermatitis in adults and pediatrics by race and ethnicity.
- Published in:
- British Journal of Dermatology, 2024, v. 191, p. 1, doi. 10.1093/bjd/ljae266.002
- By:
- Publication type:
- Article
Conjunctivitis adverse events in dupilumab clinical trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii58, doi. 10.1093/bjd/ljad498.060
- By:
- Publication type:
- Article
Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii49, doi. 10.1093/bjd/ljad498.051
- By:
- Publication type:
- Article
Long-term 5-year safety of upadacitinib in moderate-to-severe atopic dermatitis: an integrated analysis including over 7000 patient-years of exposure.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii35, doi. 10.1093/bjd/ljad498.037
- By:
- Publication type:
- Article
Lebrikizumab demonstrates significant efficacy versus placebo across racial and ethnic subgroups in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii20, doi. 10.1093/bjd/ljad498.024
- By:
- Publication type:
- Article
381 Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.009
- By:
- Publication type:
- Article
372 Early insights into the characteristics of tralokinumab patients in a real-world setting in the United States.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.003
- By:
- Publication type:
- Article
Putting the Formulation Back in Foam: Optimizing Seborrheic Dermatitis Treatment Across Diverse Hair Types.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, n. 5, p. 30
- By:
- Publication type:
- Article
Taking It Back to Basics: Re-emphasizing the Role of Moisturization in Atopic Dermatitis.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, n. 2, p. 30
- By:
- Publication type:
- Article
Dupilumab as Add-on Therapy for Management of Chronic Spontaneous Urticaria.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, n. 1, p. 10
- By:
- Publication type:
- Article
EXPERT PERSPECTIVES: Repigmentation of Vitiligo Using Topical Therapies.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, p. S33
- By:
- Publication type:
- Article
LETTERS to the Editor.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, n. 7, p. 19
- By:
- Publication type:
- Article
EXPERT PERSPECTIVES.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, n. 4, p. 10
- By:
- Publication type:
- Article
Inpatient morbidity and mortality of measles in the United States.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231329
- By:
- Publication type:
- Article
Dupilumab treatment for cholestatic pruritus.
- Published in:
- Dermatologic Therapy, 2022, v. 35, n. 3, p. 1, doi. 10.1111/dth.15296
- By:
- Publication type:
- Article
Atopic Dermatitis (Eczema).
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 3, p. 268, doi. 10.1001/jama.2022.21457
- By:
- Publication type:
- Article
Acne Treatment.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 20, p. 2087, doi. 10.1001/jama.2021.16599
- By:
- Publication type:
- Article
Honor thy Go(na)ds.
- Published in:
- Immunology & Cell Biology, 2013, v. 91, n. 10, p. 597, doi. 10.1038/icb.2013.50
- By:
- Publication type:
- Article
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53384-1
- By:
- Publication type:
- Article
Scaly papules on the trunk and vesicles on the palms and soles in two young adults.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Prevalence and association of psoriasis with seborrhoeic dermatitis: a systematic review and meta-analysis.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 8, p. 904, doi. 10.1093/ced/llae072
- By:
- Publication type:
- Article
Lichen amyloidosis: towards pathogenesis-driven targeted treatment.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 3, p. 261, doi. 10.1093/ced/llac102
- By:
- Publication type:
- Article